BioRegion News, 09.29.08
The growth of life sciences companies in the San Francisco Bay Area and elsewhere will be hamstrung over the next several months by the recent credit market turmoil, biotechnology investor-analyst G. Steven Burrill and leaders of the region’s real estate and economic-development sectors agreed here during a recent conference.
Burrill, the CEO of Burrill & Co. in San Francisco, said the credit crunch will impede the ability of life-sci businesses to obtain financing from venture capital firms — let alone the traditional financing route of selling stock in the public markets.
The growth of life sciences companies in the San Francisco Bay Area and elsewhere will be hamstrung over the next several months by the recent credit market turmoil, biotechnology investor-analyst G. Steven Burrill and leaders of the region’s real estate and economic-development sectors agreed here during a recent conference.
Burrill, the CEO of Burrill & Co. in San Francisco, said the credit crunch will impede the ability of life-sci businesses to obtain financing from venture capital firms — let alone the traditional financing route of selling stock in the public markets.